Please login to the form below

Not currently logged in
Email:
Password:

Baraclude

This page shows the latest Baraclude news and features for those working in and with pharma, biotech and healthcare.

BMS shares fall on nivolumab jitters despite solid Q4 results

BMS shares fall on nivolumab jitters despite solid Q4 results

Away from oncology, arthritis treatment Orencia (abatacept) rose 22 per cent to $397m despite an increasingly crowded market and with a new subcutaneous formulation driving growth, while hepatitis B treatment Baraclude

Latest news

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CMR

Specialising in medical device market research, our approach is people-centric and we thrive on making connections with clients and research...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics